Table 4.
Summary of various case reports found of patients with IGM
| Author | Patient age (years) | Risk factor(s) | Race/ethnicity | Treatment |
|---|---|---|---|---|
| Adams et al. | 24 | Postpartum | Not described | Indomethacin + rifampicin and isoniazid |
| Binesh et al. | 40 | Parous | Middle Eastern (Iranian) | Dexamethasone followed by prednisolone |
| Nakamura et al. | 27 | Diabetes mellitus | Asian (Japanese) | Prednisolone |
| Zabetian et al. | 43 |
Hx of BCG vaccination Parous |
Hispanic | Prednisone followed by azathioprine |
| Olfatbakhsh et al. | 30 | Pregnancy (32 weeks) | Middle Eastern (Iranian) | High-dose corticosteroid |
| Alungal et al. | 25 | None described | Indian | Corticosteroid |
| Iqbal et al. | 60 |
Hx of hormone replacement therapy Rheumatoid arthritis Asthma Pulmonary fibrosis Hiatus hernia ITP |
Not described | Conservative management |
| Salesi et al. | 23 | Pregnant (28 weeks) | Middle Eastern (Iran) |
Prednisolone Colchicine Azathioprine |
| Bes et al. | 34 | None | Middle Eastern (Turkish) | Corticosteroid |
| Bes et al. | 27 | None described | Middle Eastern (Turkish) | Corticosteroid |
Data shown include patient age, risk factors present, race/ethnicity, and treatment modalities that the patients underwent. BCG Vaccination: Bacillus Calmetter – Guérin Vaccination; ITP: Idiopathic/Immune Thrombocytopenic Purpura; Hx: History